PROCTER & GAMBLE HEALTH | WOCKHARDT | PROCTER & GAMBLE HEALTH/ WOCKHARDT |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.8 | -16.5 | - | View Chart |
P/BV | x | 10.6 | 2.6 | 402.6% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH WOCKHARDT |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
WOCKHARDT Mar-23 |
PROCTER & GAMBLE HEALTH/ WOCKHARDT |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 316 | 1,700.7% | |
Low | Rs | 3,883 | 145 | 2,671.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 184.0 | 402.6% | |
Earnings per share (Unadj.) | Rs | 138.2 | -43.1 | -320.7% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -25.7 | -604.3% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 231.7 | 193.2% | |
Shares outstanding (eoy) | m | 16.60 | 144.09 | 11.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.3 | 498.4% | |
Avg P/E ratio | x | 33.5 | -5.3 | -625.7% | |
P/CF ratio (eoy) | x | 29.8 | -9.0 | -332.1% | |
Price / Book Value ratio | x | 10.3 | 1.0 | 1,038.6% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 33,202 | 231.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 6,370 | 32.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 26,510 | 46.4% | |
Other income | Rs m | 184 | 1,220 | 15.1% | |
Total revenues | Rs m | 12,480 | 27,730 | 45.0% | |
Gross profit | Rs m | 3,247 | -1,930 | -168.2% | |
Depreciation | Rs m | 281 | 2,510 | 11.2% | |
Interest | Rs m | 8 | 3,020 | 0.3% | |
Profit before tax | Rs m | 3,142 | -6,240 | -50.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -30 | -2,824.3% | |
Profit after tax | Rs m | 2,295 | -6,210 | -37.0% | |
Gross profit margin | % | 26.4 | -7.3 | -362.7% | |
Effective tax rate | % | 27.0 | 0.5 | 5,609.1% | |
Net profit margin | % | 18.7 | -23.4 | -79.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 19,140 | 61.2% | |
Current liabilities | Rs m | 6,791 | 34,350 | 19.8% | |
Net working cap to sales | % | 40.0 | -57.4 | -69.8% | |
Current ratio | x | 1.7 | 0.6 | 309.5% | |
Inventory Days | Days | 263 | 39 | 667.3% | |
Debtors Days | Days | 343 | 11 | 3,130.1% | |
Net fixed assets | Rs m | 10,617 | 48,670 | 21.8% | |
Share capital | Rs m | 166 | 720 | 23.1% | |
"Free" reserves | Rs m | 7,265 | 32,660 | 22.2% | |
Net worth | Rs m | 7,431 | 33,380 | 22.3% | |
Long term debt | Rs m | 0 | 2,240 | 0.0% | |
Total assets | Rs m | 22,330 | 70,750 | 31.6% | |
Interest coverage | x | 409.1 | -1.1 | -38,364.5% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.4 | 147.0% | |
Return on assets | % | 10.3 | -4.5 | -228.7% | |
Return on equity | % | 30.9 | -18.6 | -166.0% | |
Return on capital | % | 42.4 | -9.0 | -468.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 3.5 | 376.2% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | 920 | 174.5% | |
Fx inflow | Rs m | 1,465 | 730 | 200.7% | |
Fx outflow | Rs m | 1,605 | 920 | 174.5% | |
Net fx | Rs m | -140 | -190 | 73.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 1,530 | 154.2% | |
From Investments | Rs m | -215 | -1,250 | 17.2% | |
From Financial Activity | Rs m | -985 | -3,150 | 31.3% | |
Net Cashflow | Rs m | 1,160 | -2,800 | -41.4% |
Indian Promoters | % | 0.0 | 51.6 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 10.3 | 193.3% | |
FIIs | % | 6.2 | 5.5 | 113.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 48.4 | 99.5% | |
Shareholders | 56,778 | 146,138 | 38.9% | ||
Pledged promoter(s) holding | % | 0.0 | 52.9 | - |
Compare PROCTER & GAMBLE HEALTH With: CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Wockhardt | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.18% | 0.92% | 0.97% |
1-Month | -0.72% | 8.23% | 2.08% |
1-Year | -0.85% | 244.60% | 55.37% |
3-Year CAGR | -8.62% | 6.33% | 15.04% |
5-Year CAGR | 5.02% | 7.73% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Wockhardt share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Wockhardt the stake stands at 51.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Wockhardt.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Wockhardt.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.